ImageneBio (IMA) Assets (2020 - 2025)
ImageneBio (IMA) posted Assets of $153.0 million for Q4 2025, down 4.91% sequentially from $160.9 million in Q3 2025, and up 860.78% YoY from $15.9 million in Q4 2024.
ImageneBio (IMA) Assets (2020 - 2025) Analysis & Trends
ImageneBio has reported Assets for 6 years, with the latest figure at $153.0 million in Q4 2025.
- Quarterly Assets rose 860.78% year-over-year to $153.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $153.0 million (up 860.78% YoY) and the FY2025 annual result came in at $153.0 million, up 860.78% from the prior year.
- Assets slipped to $153.0 million in Q4 2025 per IMA's latest filing, from $160.9 million in the prior quarter.
- Over five years, Assets peaked at $293.7 million in Q1 2021 and troughed at $15.9 million in Q4 2024.
- A 5-year average of $184.1 million and a median of $172.5 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 91.71% in 2024, then soared 860.78% in 2025.
- Over 5 years, Assets stood at $247.9 million in 2021, then slumped by 30.51% to $172.3 million in 2022, then increased by 11.51% to $192.1 million in 2023, then slumped by 91.71% to $15.9 million in 2024, then jumped by 860.78% to $153.0 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $153.0 million, $160.9 million, and $126.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | 152.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152.98 Mn |
| Sep 30, 2025 | 160.88 Mn |
| Jun 30, 2025 | 126.17 Mn |
| Mar 31, 2025 | 130.84 Mn |
| Dec 31, 2024 | 15.92 Mn |
| Sep 30, 2024 | 148.99 Mn |
| Jun 30, 2024 | 157.49 Mn |
| Mar 31, 2024 | 172.78 Mn |
| Dec 31, 2023 | 192.09 Mn |
| Sep 30, 2023 | 215.34 Mn |
| Jun 30, 2023 | 171.76 Mn |
| Mar 31, 2023 | 152.40 Mn |
| Dec 31, 2022 | 172.26 Mn |
| Sep 30, 2022 | 190.47 Mn |
| Jun 30, 2022 | 211.18 Mn |
| Mar 31, 2022 | 227.75 Mn |
| Dec 31, 2021 | 247.88 Mn |
| Sep 30, 2021 | 261.71 Mn |
| Jun 30, 2021 | 278.83 Mn |
| Mar 31, 2021 | 293.66 Mn |